medigraphic.com
ISSN 1561-3054 (Electronic)

2013, Number 1

<< Back Next >>

Rev Cubana Med Trop 2013; 65 (1)

Contribution to the study of infant cryptococosis in Cuba

Illnait ZMT, Martínez MGF, Fernández ACM, Marchena BJJ, Perurena LMR

Language: Spanish
References: 19
Page: 78-89
PDF size: 263.54 Kb.


ABSTRACT

Introduction: since 1998, an increasing number of Cryptococcus isolates obtained from HIV-negative children with meningoencephalitis was observed in the mycology laboratory at "Pedro Kourí" Institute. The global reports of child cryptococcosis are rare and usually associated with AIDS.
Objectives: to study child cryptococosis in Cuba through the comprehensive evaluation of 7 cases.
Methods: the clinical histories of seven pediatric patients with cryptococcal meningoencephalitis were examined and the obtained isolates (one per patient) were characterized. The species, variety, serotype, pathogenicity in a mouse model and amphotericin B susceptibility of the isolates were determined.
Results: average age of the children was 5.8 years, with a slight female predominance (4:3). The most common symptoms were headache, photophobia, fever and vomiting. The cytochemical study of cerebral spinal fluid and skull imaging test showed abnormalities in 6 patients. The microbiological diagnosis was made through direct examination and culture. All the isolates were from Cryptococcus neoformans serotype A and amphotericin B showed a minimum inhibitory concentration ≤ 0.125 mg/mL. In the group, 85.7 % showed phenoloxidase activity and high lethality rate in infected animals (71.4 to 100 %).
Conclusions: the prognosis of cryptococcal meningoencephalitis is closely linked to early diagnosis, therefore, this should be always kept in mind and the provided data from this study may serve as warning to attending physicians.


REFERENCES

  1. Kwon-Chung KJ, Boekhout T, Wickes BL, Fell JW. Systematics of the genus Cryptococcus and its type species C. neoformans. In: Heitman J, editor. Cryptococcus: From human pathogen to model yeast. Washington, DC: ASM Press; 2011. p. 3-15.

  2. del Poeta M, Casadevall A. Ten challenges on Cryptococcus and Cryptococcosis. Mycopathologia. 2011; DOI 10.1007/s11046-011-9473-z. Available at: http://europepmc.org/abstract/MED/21948062/reload=0;jsessionid=u13KHP1BrlA9ZCad2yOG.0

  3. Yuanjie Z, Jianghan C, Nan X, Xiaojun W, Hai W, Julin G. Cryptococcal meningitis in immunocompetent children. Mycoses. 2011;55:168-71.

  4. Perfect JR. The impact of the host on fungal infections. Am J Med. 2012. doi:10.1016/j.amjmed.2011.10.010. Available at: http://www.amjmed.com/article/S0002-9343%2811%2900905-3/abstract

  5. Illnait MT, Valdés IC, Fernández CM, Mendoza D, Perurena MR, Martínez GF. Criptococosis: una alerta necesaria. Rev Cubana Med Trop. 2001;53:224-5.

  6. Arteaga E, Capó De Paz V, Pérez-Fernández-Terán ML. Micosis oportunistas invasivas en el sida. Un estudio de 211 autopsias. Rev Iberoam Micol. 1998;15:33-5.

  7. de Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas of clinical fungi. Baarn/Reus: Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili; 2009.

  8. Wayne PA. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts; 3th Informational Supplement document M27-S3. Clinical and Laboratory Standards Institute; 2008.

  9. Lozano M, Paetznick VL, Ghannoum MA, Rex JH. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J Clin Microbiol. 1998;36:2817-22.

  10. Gumbo T, Kadzirange G, Mielke J, Gangaidzo IT, Hakim JG. Cryptococcus neoformans meningoencephalitis in African children with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 2002;21:54-6.

  11. Álvarez I, Velázquez JC, Ponce J, Gaya JA. Criptococosis infantil: presentación de 3 casos. Rev Cubana Med Trop. 2001;53(1):55-9.

  12. Bittencourt C, Orzechowski M, Gazzoni F, Severo LC. Cryptococcosis in children. Paediatric Resp Reviews. 2009;10:166-71.

  13. Cabañes JE. Micosis y zoonosis: Cryptococcus spp. Rev Iberoam Micol. 2008;25:s1-s3.

  14. Miglia KJ, Govender NP, Rossouw J, Meiring S, Mitchell TG, and the Group for enteric, respiratory, and meningeal disease surveillance in South Africa. Analyses of pediatric isolates of Cryptococcus neoformans from South Africa. J Clin Microbiol. 2011;49:307-14.

  15. Casadevall A. Cryptococci at the brain gate: break and enter or use a Trojan horse? J Clin Invest. 2010;120:1389-92.

  16. Fernández CM, Martínez G, Illnait MT, Perurena M, González M. Identificación de Cryptococcus neoformans var. neoformans en aislamientos clínicos cubanos. Rev Cubana Med Trop. 1998;50:167-9.

  17. Lin X, Nielsen K, Patel S, Heitman J. Impact of mating type, serotype, and ploidy on the virulence of Cryptococcus neoformans. Infect Immun. 2008;76:2923-38.

  18. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291-322.

  19. McTaggart LR, Lei E, Richardson SE, Hoang L, Fothergill A, Zhang SX. Rapid Identification of Cryptococcus neoformans and Cryptococcus gattii by matrix-assisted laser desorption ionizationtime of flight mass spectrometry. J Clin Microbiol. 2011;49:3050-3.




2020     |     www.medigraphic.com